TITLE

Impact of Chronic Hepatitis B Virus (HBV) Infection on Outcomes of Patients Infected with HIV in an Area Where HBV Infection Is Hyperendemic

AUTHOR(S)
Sheng, Wang-Huei; Chen, Mao-Yuan; Hsieh, Szu-Min; Hsiao, Chin-Fu; Wang, Jann-Tay; Hung, Chien-Ching; Chang, Shan-Chwen
PUB. DATE
May 2004
SOURCE
Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1471
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Between June 1994 and February 2003, a total of 111 human immunodeficiency virus (HIV)-infected patients with chronic hepatitis B virus (HBV) coinfection and 387 HIV-infected patients without HBV or hepatitis C virus coinfection were prospectively observed to assess the impact of HBV infection on outcomes of HIV- infected patients. After a median duration of observation of 25 months, coinfected patients were more likely to develop hepatitis (adjusted hazard ratio [AHR], 2.54; 95% confidence interval [CI], 1.69-3.82) and hepatic decompensation (adjusted odds ratio [AOR], 9.94; 95% CI, 1.89-52.35). Although similar proportions of the 2 patient groups had an increase in the CD4 count by ⩾100× 106 cells/L (AOR, 0.78; 95% CI, 0.45-1.36) and development of new opportunistic illnesses (AOR, 0.94; 95% CI, 0.53-1.66), HBV-infected patients had an increased risk for virologic failure (AOR, 1.76; 95% CI, 1.03-2.99) and death (AHR, 1.71; 95% CI, 1.19-2.47) after highly active antiretroviral therapy was initiated.
ACCESSION #
13077171

 

Related Articles

  • Infection Control in Jails and Prisons. Bick, Joseph A. // Clinical Infectious Diseases;10/15/2007, Vol. 45 Issue 8, p1047 

    At the end of 2005, ∼7 million people (or 1 of every 33 American adults) were either in jail, in prison, or on parole [1]. Compared with the general public, newly incarcerated inmates have an increased prevalence of human immunodeficiency virus infection, hepatitis B virus infection,...

  • HBV/HCV coinfection linked to younger age, HIV, male sex.  // Infectious Disease News;May2013, Vol. 26 Issue 5, p48 

    The article discusses research which revealed the association of hepatitis B virus/hepatitis C virus (HBV/HCV) coinfection with male sex, younger age and HIV positivity.

  • HBV/HCV coinfection with HIV continues to threaten patients.  // Infectious Disease News;Jul2009, Vol. 22 Issue 7, p7 

    The article discusses a study of the hepatitis B virus/hepatitis C virus coinfection in patients with HIV, presented at the American Conference for the Treatment of HIV.

  • Prevalence and determinants of antibodies to hepatitis C virus and markers for hepatitis B virus... Saillour, F.; Dabis, F. // BMJ: British Medical Journal (International Edition);8/24/96, Vol. 313 Issue 7055, p461 

    Evaluates the prevalence of antibodies to hepatitis C virus and serological markers for hepatitis B virus infection in HIV patients. Determinants of presence of antibodies to hepatitis C and B virus; Sexual transmission of hepatitis C.

  • Therapeutic Interventions for HIV Infection and Chronic Viral Hepatitis. Cooper, Curtis L. // Clinical Infectious Diseases;7/1/2005 Supplement, Vol. 41, pS69 

    Combination antiretroviral therapy reduces overall and liver-specific morbidity and mortality in coinfection with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and represents the most beneficial pharmaceutical treatment intervention for most coinfected patients. Antiviral...

  • Abnormal Cytokine Production by Circulating Monocytes and Dendritic Cells of Myeloid Origin in ART-Treated HIV-1+ Patients Relates to CD4+ T-Cell Recovery and HCV Co-Infection. Almeida, Maria; Cordero, Miguel; Almeida, Julia; Orfao, Alberto // Current HIV Research;Jul2007, Vol. 5 Issue 3, p325 

    HIV-1 infection is associated with dysregulation of cytokine production by peripheral blood (PB) monocytes and dendritic cells (DC), but controversial results have been reported. We aimed to analyze the effect of antiretroviral therapy (ART) on the in vitro production of inflammatory cytokines...

  • HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. ANDREONI, M.; GIACOMETTI, A.; MAIDA, I.; MERAVIGLIA, P.; RIPAMONTI, D.; SARMATI, L. // European Review for Medical & Pharmacological Sciences;2012, Vol. 16 Issue 11, p1473 

    Hepatitis C virus (HCV) is the cause of more than three-quarters of liver-related deaths in HIV-seropositive individuals and it is remarkable that today approximately one-quarter of HIV-infected individuals in Europe and the USA have a HCV coinfection. HIV/HCV coinfected patients were more...

  • Genetic Diversity of Recently Acquired and Prevalent HIV, Hepatitis B Virus, and Hepatitis C Virus Infections in US Blood Donors. Delwart, Eric; Slikas, Elizabeth; Stramer, Susan L.; Kamel, Hany; Kessler, Debra; Krysztof, David; Tobler, Leslie H.; Carrick, Danielle M.; Steele, Whitney; Todd, Deborah; Wright, David J.; Kleinman, Steven H.; Busch, Michael P. // Journal of Infectious Diseases;3/15/2012, Vol. 205 Issue 6, p875 

    Background. Genetic variations of human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) can affect diagnostic assays and therapeutic interventions. Recent changes in prevalence of subtypes/genotypes and drug/immune-escape variants were characterized by...

  • Viral Hepatitis in HIV Infection. Koziel, Margaret James; Peters, Marion G. // New England Journal of Medicine;4/5/2007, Vol. 356 Issue 14, p1445 

    The article discusses the occurrence of hepatitis C virus and hepatitis B virus infections in patients with HIV infection. The infections share routes of viral transmission. It is recommended that patients with HIV infection receive a vaccination against hepatitis A virus and hepatitis B virus....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics